Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of chronic obstructive pulmonary disease has been refined t...
Gespeichert in:
| Veröffentlicht in: | European Respiratory Journal 2017-03, Vol.49 (3) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 3 |
| container_start_page | |
| container_title | European Respiratory Journal |
| container_volume | 49 |
| creator | Vogelmeier, Claus F Criner, Gerard J Martinez, Fernando J Anzueto, Antonio Barnes, Peter J Bourbeau, Jean Celli, Bartolome R Chen, Rongchang Decramer, Marc Fabbri, Leonardo M Frith, Peter Halpin, David M.G López Varela, M. Victorina Nishimura, Masaharu Roche, Nicolas Rodriguez-Roisin, Roberto Sin, Don D Singh, Dave Stockley, Robert Vestbo, Jørgen Wedzicha, Jadwiga A Agusti, Alvar |
| description | This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed. |
| format | Article |
| fullrecord | <record><control><sourceid>kuleuven</sourceid><recordid>TN_cdi_kuleuven_dspace_123456789_583455</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>123456789_583455</sourcerecordid><originalsourceid>FETCH-kuleuven_dspace_123456789_5834553</originalsourceid><addsrcrecordid>eNqVjUFuwjAQRb1opULpHWbXRUGyMQmkW6B0QQUq3UdDmARDYiN7jOAAvXcj1AO0q_--9PT_nejITOqBynT6ILohHKRU6Uirjvhe1G6LNWzYI1N1hdJ54D3BzGBlXTChDx9osaKGLPcB7Q7Wns5tMc6CK2G6986aAlbbwD4WbM4Ey2irdiEQBoKhVGP4pJPz_AqL1XIG8wsV8SZuYtOgv_bEfYl1oKfffBTPb_Ov6fvgGGuK7Vm-CycsKFdDPUrS8STLk0lLif6P-fI3M-cL6x9pDF7M</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary</title><source>Lirias (KU Leuven Association)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Vogelmeier, Claus F ; Criner, Gerard J ; Martinez, Fernando J ; Anzueto, Antonio ; Barnes, Peter J ; Bourbeau, Jean ; Celli, Bartolome R ; Chen, Rongchang ; Decramer, Marc ; Fabbri, Leonardo M ; Frith, Peter ; Halpin, David M.G ; López Varela, M. Victorina ; Nishimura, Masaharu ; Roche, Nicolas ; Rodriguez-Roisin, Roberto ; Sin, Don D ; Singh, Dave ; Stockley, Robert ; Vestbo, Jørgen ; Wedzicha, Jadwiga A ; Agusti, Alvar</creator><creatorcontrib>Vogelmeier, Claus F ; Criner, Gerard J ; Martinez, Fernando J ; Anzueto, Antonio ; Barnes, Peter J ; Bourbeau, Jean ; Celli, Bartolome R ; Chen, Rongchang ; Decramer, Marc ; Fabbri, Leonardo M ; Frith, Peter ; Halpin, David M.G ; López Varela, M. Victorina ; Nishimura, Masaharu ; Roche, Nicolas ; Rodriguez-Roisin, Roberto ; Sin, Don D ; Singh, Dave ; Stockley, Robert ; Vestbo, Jørgen ; Wedzicha, Jadwiga A ; Agusti, Alvar</creatorcontrib><description>This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.</description><identifier>ISSN: 0903-1936</identifier><language>eng</language><publisher>Published jointly by the Society and Munksgaard</publisher><ispartof>European Respiratory Journal, 2017-03, Vol.49 (3)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,315,778,782,27843</link.rule.ids></links><search><creatorcontrib>Vogelmeier, Claus F</creatorcontrib><creatorcontrib>Criner, Gerard J</creatorcontrib><creatorcontrib>Martinez, Fernando J</creatorcontrib><creatorcontrib>Anzueto, Antonio</creatorcontrib><creatorcontrib>Barnes, Peter J</creatorcontrib><creatorcontrib>Bourbeau, Jean</creatorcontrib><creatorcontrib>Celli, Bartolome R</creatorcontrib><creatorcontrib>Chen, Rongchang</creatorcontrib><creatorcontrib>Decramer, Marc</creatorcontrib><creatorcontrib>Fabbri, Leonardo M</creatorcontrib><creatorcontrib>Frith, Peter</creatorcontrib><creatorcontrib>Halpin, David M.G</creatorcontrib><creatorcontrib>López Varela, M. Victorina</creatorcontrib><creatorcontrib>Nishimura, Masaharu</creatorcontrib><creatorcontrib>Roche, Nicolas</creatorcontrib><creatorcontrib>Rodriguez-Roisin, Roberto</creatorcontrib><creatorcontrib>Sin, Don D</creatorcontrib><creatorcontrib>Singh, Dave</creatorcontrib><creatorcontrib>Stockley, Robert</creatorcontrib><creatorcontrib>Vestbo, Jørgen</creatorcontrib><creatorcontrib>Wedzicha, Jadwiga A</creatorcontrib><creatorcontrib>Agusti, Alvar</creatorcontrib><title>Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary</title><title>European Respiratory Journal</title><description>This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.</description><issn>0903-1936</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>FZOIL</sourceid><recordid>eNqVjUFuwjAQRb1opULpHWbXRUGyMQmkW6B0QQUq3UdDmARDYiN7jOAAvXcj1AO0q_--9PT_nejITOqBynT6ILohHKRU6Uirjvhe1G6LNWzYI1N1hdJ54D3BzGBlXTChDx9osaKGLPcB7Q7Wns5tMc6CK2G6986aAlbbwD4WbM4Ey2irdiEQBoKhVGP4pJPz_AqL1XIG8wsV8SZuYtOgv_bEfYl1oKfffBTPb_Ov6fvgGGuK7Vm-CycsKFdDPUrS8STLk0lLif6P-fI3M-cL6x9pDF7M</recordid><startdate>201703</startdate><enddate>201703</enddate><creator>Vogelmeier, Claus F</creator><creator>Criner, Gerard J</creator><creator>Martinez, Fernando J</creator><creator>Anzueto, Antonio</creator><creator>Barnes, Peter J</creator><creator>Bourbeau, Jean</creator><creator>Celli, Bartolome R</creator><creator>Chen, Rongchang</creator><creator>Decramer, Marc</creator><creator>Fabbri, Leonardo M</creator><creator>Frith, Peter</creator><creator>Halpin, David M.G</creator><creator>López Varela, M. Victorina</creator><creator>Nishimura, Masaharu</creator><creator>Roche, Nicolas</creator><creator>Rodriguez-Roisin, Roberto</creator><creator>Sin, Don D</creator><creator>Singh, Dave</creator><creator>Stockley, Robert</creator><creator>Vestbo, Jørgen</creator><creator>Wedzicha, Jadwiga A</creator><creator>Agusti, Alvar</creator><general>Published jointly by the Society and Munksgaard</general><scope>FZOIL</scope></search><sort><creationdate>201703</creationdate><title>Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary</title><author>Vogelmeier, Claus F ; Criner, Gerard J ; Martinez, Fernando J ; Anzueto, Antonio ; Barnes, Peter J ; Bourbeau, Jean ; Celli, Bartolome R ; Chen, Rongchang ; Decramer, Marc ; Fabbri, Leonardo M ; Frith, Peter ; Halpin, David M.G ; López Varela, M. Victorina ; Nishimura, Masaharu ; Roche, Nicolas ; Rodriguez-Roisin, Roberto ; Sin, Don D ; Singh, Dave ; Stockley, Robert ; Vestbo, Jørgen ; Wedzicha, Jadwiga A ; Agusti, Alvar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kuleuven_dspace_123456789_5834553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vogelmeier, Claus F</creatorcontrib><creatorcontrib>Criner, Gerard J</creatorcontrib><creatorcontrib>Martinez, Fernando J</creatorcontrib><creatorcontrib>Anzueto, Antonio</creatorcontrib><creatorcontrib>Barnes, Peter J</creatorcontrib><creatorcontrib>Bourbeau, Jean</creatorcontrib><creatorcontrib>Celli, Bartolome R</creatorcontrib><creatorcontrib>Chen, Rongchang</creatorcontrib><creatorcontrib>Decramer, Marc</creatorcontrib><creatorcontrib>Fabbri, Leonardo M</creatorcontrib><creatorcontrib>Frith, Peter</creatorcontrib><creatorcontrib>Halpin, David M.G</creatorcontrib><creatorcontrib>López Varela, M. Victorina</creatorcontrib><creatorcontrib>Nishimura, Masaharu</creatorcontrib><creatorcontrib>Roche, Nicolas</creatorcontrib><creatorcontrib>Rodriguez-Roisin, Roberto</creatorcontrib><creatorcontrib>Sin, Don D</creatorcontrib><creatorcontrib>Singh, Dave</creatorcontrib><creatorcontrib>Stockley, Robert</creatorcontrib><creatorcontrib>Vestbo, Jørgen</creatorcontrib><creatorcontrib>Wedzicha, Jadwiga A</creatorcontrib><creatorcontrib>Agusti, Alvar</creatorcontrib><collection>Lirias (KU Leuven Association)</collection><jtitle>European Respiratory Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vogelmeier, Claus F</au><au>Criner, Gerard J</au><au>Martinez, Fernando J</au><au>Anzueto, Antonio</au><au>Barnes, Peter J</au><au>Bourbeau, Jean</au><au>Celli, Bartolome R</au><au>Chen, Rongchang</au><au>Decramer, Marc</au><au>Fabbri, Leonardo M</au><au>Frith, Peter</au><au>Halpin, David M.G</au><au>López Varela, M. Victorina</au><au>Nishimura, Masaharu</au><au>Roche, Nicolas</au><au>Rodriguez-Roisin, Roberto</au><au>Sin, Don D</au><au>Singh, Dave</au><au>Stockley, Robert</au><au>Vestbo, Jørgen</au><au>Wedzicha, Jadwiga A</au><au>Agusti, Alvar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary</atitle><jtitle>European Respiratory Journal</jtitle><date>2017-03</date><risdate>2017</risdate><volume>49</volume><issue>3</issue><issn>0903-1936</issn><abstract>This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.</abstract><pub>Published jointly by the Society and Munksgaard</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0903-1936 |
| ispartof | European Respiratory Journal, 2017-03, Vol.49 (3) |
| issn | 0903-1936 |
| language | eng |
| recordid | cdi_kuleuven_dspace_123456789_583455 |
| source | Lirias (KU Leuven Association); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| title | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T11%3A04%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kuleuven&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Global%20Strategy%20for%20the%20Diagnosis,%20Management,%20and%20Prevention%20of%20Chronic%20Obstructive%20Lung%20Disease%202017%20Report:%20GOLD%20Executive%20Summary&rft.jtitle=European%20Respiratory%20Journal&rft.au=Vogelmeier,%20Claus%20F&rft.date=2017-03&rft.volume=49&rft.issue=3&rft.issn=0903-1936&rft_id=info:doi/&rft_dat=%3Ckuleuven%3E123456789_583455%3C/kuleuven%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |